Insider · CIK 0001575408

Islam Saqib

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001575408

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−955K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Performance Share UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−580K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−22.8K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−770K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−176K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−325K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−260K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−250K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−109K sh	—	—	0
2025-06-25	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-05-28	PASGPassage BIO, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+202K sh	—	—	201,857
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.8K sh	$52.97	−$625K	992,069
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−23.6K sh	$54.24	−$1.28M	968,469
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.6K sh	$55.15	−$640K	956,869
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,400 sh	$56.13	−$78.6K	955,469
2025-03-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−600 sh	$56.89	−$34.1K	954,869
2025-02-27	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−30.8K sh	$53.41	−$1.64M	1,003,869
2025-02-20	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−24.3K sh	$60.10	−$1.46M	1,039,693
2025-02-20	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,068 sh	$61.24	−$310K	1,034,625
2025-02-14	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−10.7K sh	$59.92	−$639K	1,063,953
2025-02-12	SpringWorks Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+85.3K sh	—	—	1,087,811
2025-02-12	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−13.2K sh	$59.28	−$782K	1,074,625
2025-02-10	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−48K sh	$53.30	−$2.56M	1,002,502
2025-01-10	SpringWorks Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+74.8K sh	—	—	1,050,502
2025-01-10	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+109K sh	—	—	109,329
2025-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.4K sh	$38.86	−$480K	975,668
2025-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.9K sh	$38.19	−$492K	988,027
2025-01-04	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−13.5K sh	$38.19	−$514K	1,000,899
2024-12-02	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−45K sh	$41.33	−$1.86M	1,018,357
2024-12-02	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,989 sh	$41.85	−$167K	1,014,368
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−32.4K sh	$40.10	−$1.3M	1,079,968
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,908 sh	$41.10	−$407K	1,070,060
2024-09-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,692 sh	$42.07	−$282K	1,063,368
2024-06-20	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−33.2K sh	$39.40	−$1.31M	1,128,128
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,760 sh	$40.57	−$355K	1,119,368
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,600 sh	$41.40	−$273K	1,112,768
2024-06-03	SpringWorks Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−400 sh	$42.09	−$16.8K	1,112,368
2024-05-21	PASGPassage BIO, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+47.7K sh	—	—	47,693
2024-01-08	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.9K sh	$41.53	−$744K	256,264
2024-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.9K sh	$37.96	−$489K	274,168
2024-01-04	SpringWorks Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+88K sh	—	—	287,053
2024-01-04	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2023-11-30	SpringWorks Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+199K sh	—	—	199,053
2023-06-27	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-05-25	PASGPassage BIO, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2023-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,097 sh	$26.41	−$108K	905,104
2023-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−8,400 sh	$27.52	−$231K	909,201
2023-01-05	SpringWorks Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+84.2K sh	—	—	917,601

Recent filings

Accepted (ET)
Jun 264
Islam Saqib0001575408-26-000002
SEC(opens sec.gov)
Jul 24
Islam Saqib0001104659-25-065298
SEC(opens sec.gov)
Jun 274
Islam Saqib0001415889-25-018385
SEC(opens sec.gov)
May 304
Islam Saqib0001415889-25-015056
SEC(opens sec.gov)
Mar 54
Islam Saqib0001104659-25-021005
SEC(opens sec.gov)
Feb 244
Islam Saqib0001104659-25-016617
SEC(opens sec.gov)

Companies

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130